Biogen Inc (BIIB)
129.50
+3.91
(+3.11%)
USD |
NASDAQ |
May 19, 16:00
129.77
+0.27
(+0.21%)
After-Hours: 20:00
Biogen Market Cap: 18.98B for May 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen Inc | 148.37B |
| Johnson & Johnson | 366.95B |
| Eli Lilly and Co | 678.69B |
| Moderna Inc | 10.21B |
| Merck & Co Inc | 193.96B |
Market Cap Related Metrics
| PE Ratio | 12.78 |
| PS Ratio | 1.928 |
| PEG Ratio | 0.4830 |
| Price to Book Value | 1.118 |
| Price to Free Cash Flow | 8.243 |
| Price | 129.50 |
| Earnings Yield | 7.82% |
| PEGY Ratio | 0.4830 |
| Operating PE Ratio | 8.321 |
| Normalized PE Ratio | 10.38 |